Defibrillators Market Size, Share, Trends, Analysis and Forecasts To 2022
Global Defibrillators market is accounted for $ 10.61 billion in 2015 and is expected to reach $ 19.31 billion by 2022 growing at a CAGR of 8.9 %. The defibrillation is a procedure comprising of delivering an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse during cardiac arrest. Technological advancement of defibrillators, geriatric population with high risk of target diseases and increasing number of training and awareness programs across the globe are proliferating the market. However, product failures & recalls and lack of awareness about sudden cardiac arrest( SCA) are the factors inhibiting the market.
Download Sample Report @ https:// marketreportscenter. com / request-sample / 451962
Wearable Cardioverter Defibrillators( WCDS) in External Defibrillators segment is expected to gain its momentum through dominating the market, owing to its user-friendly nature and wearable techniques. Hospitals, Clinics, & Cardiac Centers segment is expected to throttle the market in order to its necessity in healthcare. Asia Pacific is accounted for the largest share of the market attributing to large number of healthcare reforms, high prevalence of heart failures, and increased focus of key players on developing technologically advanced cost-effective defibrillators.
Some of the key players of the Defibrillators market include Access Cardio Systems, BIOTRONIC SE & Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, Defibtech LLC, Fukuda Denshi USA Inc., GE Healthcare, HeartSine Technologies, Koninklijk, Philips N. V., Medtronic Inc., Metrax, Nihon Kohden corporation, Philips Healthcare, Physio-Control Inc., Progetti S. R. I, Schiller AG, Sorin Group, St. Jude Medical Inc., Welch Allyn and ZOLL Medical Corporation.
End-Users Covered: Alternate Care Markets Home Care Hospitals, Clinics, & Cardiac Centers Pre-Hospitals Public Access Markets
Product Types Covered: Implantable Cardioverter Defibrillators( ICDS) Subcutaneous Implantable Cardioverter Defibrillators( S-ICDS) Transvenous Implantable Cardioverter Defibrillators( T-ICDS) Biventricular ICDS / Cardiac Resynchronization Therapy Defibrillators( CRT-DS) Dual-Chamber ICDS Single-Chamber ICDS External Defibrillators Automated External Defibrillators( AEDS)